The DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond?
Open accessAbstract
Blue light, particularly in the wavelength range of 405–470 nm, has attracted increasing attention due to its intrinsic antimicrobial effect without the addition of exogenous photosensitizers. In addition, it is commonly accepted that blue light is much less detrimental to mammalian cells than ultraviolet irradiation, which is another light-based antimicrobial approach being investigated. In this review, we discussed the blue light sensing systems in microbial cells, antimicrobial efficacy of blue light, the mechanism of antimicrobial effect of blue light, the effects of blue light on mammalian cells, and the effects of blue light on wound healing. It has been reported that blue light can regulate multi-cellular behavior involving cell-to-cell communication via blue light receptors in bacteria, and inhibit biofilm formation and subsequently potentiate light inactivation. At higher radiant exposures, blue light exhibits a broad-spectrum antimicrobial effect against both Gram-positive and Gram-negative bacteria. Blue light therapy is a clinically accepted approach for Propionibacterium acnes infections. Clinical trials have also been conducted to investigate the use of blue light for Helicobacter pylori stomach infections and have shown promising results. Studies on blue light inactivation of important wound pathogenic bacteria, including Staphylococcus aureus and Pseudomonas aeruginosa have also been reported. The mechanism of blue light inactivation of P. acnes, H. pylori, and some oral bacteria is the photo-excitation of intracellular porphyrins and the subsequent production of cytotoxic reactive oxygen species. Although it may be the case that the mechanism of blue light inactivation of wound pathogens (e.g., S. aureus, P. aeruginosa) is the same as that of P. acnes, this hypothesis has not been rigorously tested. Limited and discordant results have been reported regarding the effects of blue light on mammalian cells and wound healing. Under certain wavelengths and radiant exposures, blue light may cause cell dysfunction by the photo-excitation of blue light sensitive chromophores, including flavins and cytochromes, within mitochondria or/and peroxisomes. Further studies should be performed to optimize the optical parameters (e.g., wavelength, radiant exposure) to ensure effective and safe blue light therapies for infectious disease. In addition, studies are also needed to verify the lack of development of microbial resistance to blue light.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Photodynamic therapy: a new antimicrobial approach to infectious disease?
Hamblin, M. R., & Hasan, T. (2004) · Photochemical & Photobiological Sciences · doi:10.1039/b311900a · Cited by 2,035
Self-citationPhotodynamic antimicrobial chemotherapy (PACT)
Wainwright, M. (1998) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/42.1.13 · Cited by 1,233
Biphasic Dose Response in Low Level Light Therapy
Huang, Y.-Y., Chen, A. C.-H., Carroll, J. D., & Hamblin, M. R. (2009) · Dose-Response · doi:10.2203/dose-response.09-027.hamblin · Cited by 1,162
Self-citationBiphasic Dose Response in Low Level Light Therapy – an Update
Huang, Y.-Y., Sharma, S. K., Carroll, J., & Hamblin, M. R. (2011) · Dose-Response · doi:10.2203/dose-response.11-009.hamblin · Cited by 854
Self-citationPhotodynamic therapy for localized infections—State of the art
Dai, T., Huang, Y.-Y., & Hamblin, M. R. (2009) · Photodiagnosis and Photodynamic Therapy · doi:10.1016/j.pdpdt.2009.10.008 · Cited by 795
Self-citationThe Chemical and Biological Versatility of Riboflavin
Massey, V. (2000) · Biochemical Society Transactions · doi:10.1042/0300-5127:0280283 · Cited by 751
Blue Light Induces Mitochondrial DNA Damage and Free Radical Production in Epithelial Cells
Godley, B. F., Shamsi, F. A., Liang, F.-Q., Jarrett, S. G., Davies, S., & Boulton, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m502194200 · Cited by 444
Tavares, A., Carvalho, C. M. B., Faustino, M. A., Neves, M. G. P. M. S., Tomé, J. P. C., Tomé, A. C., Cavaleiro, J. A. S., Cunha, Â., Gomes, N. C. M., Alves, E., et al. (2010) · Marine Drugs · doi:10.3390/md8010091 · Cited by 419
Maclean, M., MacGregor, S. J., Anderson, J. G., & Woolsey, G. (2009) · Applied and Environmental Microbiology · doi:10.1128/aem.01892-08 · Cited by 404
Ashkenazi, H. (2003) · FEMS Immunology and Medical Microbiology · doi:10.1016/s0928-8244(02)00423-6 · Cited by 373
Cited by
Nano-Strategies to Fight Multidrug Resistant Bacteria—“A Battle of the Titans”
Baptista, P. V., McCusker, M. P., Carvalho, A., Ferreira, D. A., Mohan, N. M., Martins, M., & Fernandes, A. R. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.01441 · Cited by 881
Light based anti-infectives: ultraviolet C irradiation, photodynamic therapy, blue light, and beyond
Yin, R., Dai, T., Avci, P., Jorge, A. E. S., de Melo, W. C., Vecchio, D., Huang, Y.-Y., Gupta, A., & Hamblin, M. R. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2013.08.009 · Cited by 286
Self-citationSadowska, M., Narbutt, J., & Lesiak, A. (2021) · Life · doi:10.3390/life11070670 · Cited by 74
Metadata
- Authors
- Dai, T., Gupta, A., Murray, C. K., Vrahas, M. S., Tegos, G. P., & Hamblin, M. R.
- Venue
- Drug Resistance Updates
- Publisher
- Elsevier BV
- Published
- 2012-08
- Volume
- 15
- Issue
- 4
- Pages
- 223-236
- ISSN
- 1368-7646 (ISSN-L)
- OpenAlex
- W2008852039
- Cited by
- 357
- References
- 63
- FWCI
- 10.43
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? https://app.cochat.ai/papers/10.1016/j.drup.2012.07.001
- The paper
- Dai, T., Gupta, A., Murray, C. K., Vrahas, M. S., Tegos, G. P., & Hamblin, M. R. (2012). Blue light for infectious diseases: Propionibacterium acnes, Helicobacter pylori, and beyond? Drug Resistance Updates. https://doi.org/10.1016/j.drup.2012.07.001
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.